Biogen Avonex Defense: Seek Broader Label, Boost Promo/Patient Efforts

Biogen's plan to defend Avonex from Serono's entry with Rebif includes pursuing a broader multiple sclerosis label while enhancing marketing and patient retention efforts to protect current usage